期刊文献+

丙戊酸钠通过激活内源性凋亡途径诱导乳腺癌细胞凋亡的实验研究 被引量:3

Valproate acid sodium induces human breast cancer cell apoptosis by activating intrinsic pathway
原文传递
导出
摘要 目的探讨丙戊酸钠(VPA)诱导乳腺癌细胞凋亡的作用。方法乳腺癌细胞株MCF-7细胞分为0.75~4.0 mmoL/L VPA实验组、对照组(不加VPA)及VPA与caspase抑制剂共同作用组。Annexin V-PI双染法流式细胞术检测细胞凋亡,间接免疫荧光法定量分析及分光光度法检测caspase- 3、caspase-8、caspase-9蛋白丰度和活性,探讨VPA诱导凋亡的机制,同时检测VPA与caspase-3、caspase- 8、caspase-9特异性抑制剂协同作用后细胞凋亡的变化来加以验证。结果各浓度VPA干预MCF-7细胞48 h后,细胞凋亡率显著增加,caspase-3、caspase-9活性升高、蛋白表达明显上调,与对照组相比有显著差异(F=552.1、610.9、312.8、222.8、70.3,均P〈0.001);而caspase-8活性及蛋白表达未见明显改变;1.5、3.0 mmol/L VPA与caspase-3、caspase-9相应特异性抑制剂共同作用组,细胞凋亡率均较VPA组显著降低(t=109.0、28.7、18.7、32.3,均P〈0.005);VPA与caspase-8特异性抑制剂共同作用组细胞凋亡率与VPA组比较无明显改变(t=1.03、2.32,均P〉0.05)。结论VPA可通过激活caspase-9介导的内源性凋亡途径,明显诱导乳腺癌细胞凋亡,具有较好的临床应用价值。 Objective To identify the inducing effect of valproate acid sodium(VPA) on human bresat cancer cells apoptosis and study the molecular mechanisms. Methods Cultured MCF-7 cells were divided into VPA groups( treated with 0. 75-4.0 mmol/L VPA) ,control group( without VPA treating) and VPA plus caspase specific inhibitors group. Apoptosis rate was analyzed by flow cytometric with Annexin V/PI staining assay. The activities and protein expressions of caspase-3, caspase-8, caspase-9 were detected by spectrophotometry and indirect immunofluorescence technique respectively. Explored the mechanism of VPA inducing apoptosis, and confirmed it by detecting apoptosis changes after the cells being treated with VPA and specific inhibitors of caspase-3,caspase-8 and caspase-9. Results The apoptosis rates of MCF-7 cells increased significantly (F = 552. 1, P 〈 0. 001 ) after being treated with 0. 75-4. 0 mmol/L VPA for 48 h. The activities and protein expressions of caspase-3, caspase-9 were up-regulated significantly compared to the control group (F = 610. 9, 312. 8, 222. 8, 70. 3, P 〈 0. 001 ) ;while the activity and protein expression of caspase-8 had no difference between experimental groups and control group ( P 〉 0.05 ). The apoptosis rates of MCF-7 cells treated with 1.5, 3.0mmol/L VPA and specific inhibitors of caspase-3, caspase-9 together were lower than those in the groups with VPA treated alone ( t = 109. 0, 28.7, 18.7, 32. 3, P 〈0. 005). The apoptosis rate in group treated with VPA and caspase-8 specific inhibitor remained the same as that of VPA group( t = 1.03, 2.32, P 〉 0. 05). Conclusion VPA can induce human breast cancer cells apoptosis effectively by activating the intrinsic pathway mediated by caspase-9, and it may be used as a potential drug in clinical treatment of human breast cancer.
出处 《国际肿瘤学杂志》 CAS 2007年第8期626-629,共4页 Journal of International Oncology
关键词 乳腺肿瘤 细胞系 肿瘤 细胞凋亡 半胱氨酸天冬氨酸蛋白酶 分子作用机制 Breast neoplasms Cell line, tumor Apoptosis Caspases Molecular mechanisms of ac-tion
  • 相关文献

参考文献13

  • 1Vigushin DM, Coombes RC. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs, 2002,13( 1 ) :1-13.
  • 2Rosato RR, Grant S. Histone deacetylase inhibitors in cancer therapy. Cancer Biol Ther, 2003,2(1) :30-37.
  • 3Dokmanovlc M, Marks PA. Prospects : histone deacetylase inhibitors. J Cell Biochem, 2005,96(2) : 293-304.
  • 4Marks P, Rifkind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer, 2001,1 ( 3 ) : 194-202.
  • 5Kwon SH, Ahn SH, Kim YK, et al. Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J Biol Chem,2002, 277 ( 3 ) : 2073- 2080.
  • 6Gillenwater A, Zou CP, Zhong M, et al. Effects of sodium butyrate on growth, differentiation and apoptosis in head and neck squamous carcinoma cell lines. Head Neck, 2000, 22(3) :247-256.
  • 7Rocchi P, Tonelli R, Camerin C, et al. p21Wafl/Cipl is a common target induced by short-chain fatty acid HDAC inhibitors ( valproic acid, tributyrin and sodium butyrate) in neuroblastoma ceils. Oncol Rep, 2005, 13(6) :1139-1144.
  • 8Catalano MG, Fortunati N, Pugliese M, et al. Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab, 2004,90 (3) :1383-1389.
  • 9Turner BM. Cellular memory and the histone code. Cell, 2002, 111 (3) : 285-291.
  • 10Choi JH, Kwon HJ, Yoon BI, et al. Expression profile of histone deacetylase in gastric cancer tissues. Jpn J Cancer Res, 2001, 92 (12) :1300-1304.

同被引文献34

  • 1熊芳,肖大光,曾朝阳,熊炜,阳菊华.利用基因表达系列分析数据库进行数字化基因差异显示筛选胃癌相关基因[J].中国医师杂志,2006,8(3):302-305. 被引量:2
  • 2许沈华,余传定,牟瀚舟,姜志明,朱赤红,刘祥麟.用基因芯片筛选胃黏膜癌变相关基因[J].中华胃肠外科杂志,2006,9(5):436-440. 被引量:6
  • 3时昌文,李杰,赵霞,曹莉莉,孙京杰.丙戊酸钠对肝癌细胞系HepG2的生长抑制作用[J].中华肿瘤防治杂志,2007,14(7):510-513. 被引量:12
  • 4Ishihama K, Yamakawa M, Semba S, Takeda H, et al. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. J Clin Pathol, 2007,60( 11 ) : 1205-1210.
  • 5Turner BM. Cellular memory and the histone code. Cell, 2002, 111 (3) : 285 -291.
  • 6Dokmanovic M;Marks PA. Prospects: histone deacetylase inhibitors. J Cell Biochem ,2005,96 (2) : 293 -304.
  • 7Marks PA, Rifkind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies. Nature ,2001,1 ( 3 ) : 194-202.
  • 8Yang H, Hoshino K, Sanchez-Gonzalez B, et al. Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid. Leuk Res, 2005, 29(7) :739-748.
  • 9Tabe Y, Konopleva M, Contractor R, et al. Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells. Blood, 2006,107(4) :1546-1554.
  • 10Liu T, Tee AE, Porto A, et al. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Natl Acad Sci U S A,2007,104(47) :18682-18687.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部